GeneDx CEO Katherine Stueland likes the potential of newborn testing, but she says her Stamford, Connecticut, company is ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...

On TVM's Xtra, newly co-opted Labour MP Ramona Attard has called for greater public awareness and free access to ...

The following is a summary of “Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: ...

The ability to predict spirometry-defined COPD was significantly better when a modified lung function questionnaire score was ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc. announced ...

Mallards over the 30 percent farm-raised DNA threshold are showing poor migration habits The author's drake mallard and three ...

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes-insights that could help doctors ...

A new coverage determination will prevent Medicare patients with certain cancers from accessing genetic testing, a move that advocates and testing companies say will severely limit early interventions ...

GAITHERSBURG, Md. - GeneDx (NASDAQ: WGS), a genomic insights company valued at $1.64 billion, has launched its services on Aura, Epic's specialty diagnostics suite, to facilitate advanced genetic ...